Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Health

FDA Approves the First Drug for Reducing Risk of HIV Infection

80beatsBy Veronique GreenwoodJuly 17, 2012 9:11 PM

Newsletter

Sign up for our email newsletter for the latest science news

Thanks to modern treatments, HIV, though incurable, is far from the death sentence it once was. But it is still a life sentence, coming with the high cost, both personal and economic, of chronic disease, making avoiding infection in the first place a major goal for public health agencies. To that end, after numerous trials, the FDA has now approved Truvada, a combination drug that is already being used to treat HIV, as a preventative. Truvada and its component drugs have made headlines in recent years as researchers tested them out in what they call "high-risk populations": the uninfected partners of people who have HIV, African women, and other groups that are at a higher risk than the general population for contracting the disease. Although condoms can help prevent HIV transmission, people don't always use them, and alternatives that can be applied or taken before sex, like gels and pills, may help these populations protect themselves. In one trial, Truvada reduced the risk of contracting HIV by 90% in gay men who took it religiously. In another, this one with 4,800 heterosexual couples in which one member had the disease, it reduced the rate of transmission by 75%.

2 Free Articles Left

Want it all? Get unlimited access when you subscribe.

Subscribe

Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 70%

Subscribe

Already a subscriber? Register or Log In